OR Kaitlyn Kelley

Welcome to the Division of Surgical Oncology

The Division of Surgical Oncology is at the forefront of treatment for patients with breast, GI stromal tumor, hepatobiliary-pancreatic, and peritoneal malignancies. Our faculty are active in basic and clinical research, funded by the National Institutes of Health/National Cancer Institute, the Veteran's Administration, and Stand Up to Cancer, among others. Most of these studies use molecularly targeted or other novel therapeutics not offered anywhere else in the nation.


Dr. Jula Veerapong

Dr. Jason Sicklick,

a surgical oncologist and Associate Professor of Surgery, was recently featured in the Los Angeles Times about his work studying GIST--gastrointestinal stromal tumors. Dr. Sicklick was awarded the Rare Champion of Hope Award this year by Global Genes, one of the leading global advocacy and support organizations for patients with rare diseases. Dr. Sicklick was also named a recipient of the prestigious James IV Association of Surgeons Traveling Fellowship, which pays a stipend allowing young, academic surgeons a four-week period of foreign travel, with a goal of promoting communication and collaboration in the surgical community. 

Read More

Stand Up To Cancer

Surgeon-scientists in UC San Diego's Department of Surgery are advancing efforts to fight the disease for tomorrow's patients, while providing the best possible care for today's patients. A team of UC San Diego researchers and physicians, co-led by Dr. Andrew Lowy, Chief of the Division of Surgical Oncology, was recently awarded a $1 million Stand Up To Cancer (SU2C) grant to test drugs that block signals that play a critical role in driving growth and progression of pancreatic cancer. This is the third SU2C grant targeting pancreatic cancer to be awarded to UC San Diego researchers.